With NPAT of $2.8 to 3.2M, it implies current valuation of P/E of 16 to 14. I am glad CMP's performance matches its share price. Nothing crazy about valuation. It's a relatively safe investment, in time of turbulent market.
I think spin-off is less likely, because CMP sees a lot of unlocked value in DWP/Neuroscan. With support of AUS government, it would be embarrassing to sell the division cheap.
I think CMP is looking for strategic partnership in both divisions, which are wonderful business/hidden champions.
With NPAT of $2.8 to 3.2M, it implies current valuation of P/E...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.70M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22900 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |
Day chart unavailable